BioSpace News Archive

Deals

DaVita Inc. Announces Offering of $1.5 Billion Senior Notes

DaVita Inc. announced that it has commenced a private offering of $1.5 billion aggregate principal amount of senior notes due 2031, subject to market and other conditions.

August 6, 2020
·
8 min read
Drug Development

Precigen Triple-Gene Provides Six-month Follow-up Data from Phase I Study of INXN-4001, a Multigenic Investigational Therapeutic Candidate for Heart Failure

Precigen Triple-Gene, a clinical stage cardiovascular gene therapy company and majority-owned subsidiary of Precigen, Inc. (Nasdaq: PGEN), today announced six-month follow-up data from the Phase I trial of INXN-4001 (clinical trial identifier: NCT03409627),

August 6, 2020
·
5 min read
Business

Alnylam Announces Planned Transition of Barry Greene, President

Greene to Pursue New Opportunities at End-Q3, While Remaining a Consultant for Up to Two Years to Ensure Orderly Transition

August 6, 2020
·
9 min read